A mutation in exon 7 of the human cytochrome P-4501 Al gene as marker for sensitivity to anti-cancer drugs?
1997
Mutation in CYPIA1 Gene and Cancer Drug Sensitivity
publication
Author Information
Author(s): WHM Peters, HMJ Roelofs
Primary Institution: St Radboud University Hospital
Hypothesis
Is there a relationship between a mutation in exon 7 of the CYPIA1 gene and sensitivity to anti-cancer drugs?
Conclusion
Investigating the mutation in exon 7 of the CYPIA1 gene may help in selecting patients for chemotherapy based on their sensitivity to anti-cancer drugs.
Supporting Evidence
- Low CYP activities could result in cells being insensitive to anti-cancer agents.
- Deficient inducibility of CYPIA1 enzyme activity could lead to failure in activation of anti-cancer drugs.
- The mutation leads to an enhancement of CYPIA1 enzyme activity, which can improve drug activation.
Takeaway
Some people have a change in a gene that might help them respond better to cancer drugs, and finding this change could help doctors choose the right treatment.
Methodology
The presence of the CYPIA1 exon 7 mutation was investigated using PCR and restriction enzyme digestion.
Participant Demographics
The mutation is present in about 17% of Dutch Caucasians.
Want to read the original?
Access the complete publication on the publisher's website